What is NDC 71335-2123?

71335-2123 is the product NDC for Ezetimibe, Ezetimibe 10 mg/1 tablet, listed with the FDA by Bryant Ranch Prepack. It has 5 package NDCs, shown above in 10- and 11-digit form.

Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Ezetimibe?

40 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Ezetimibe NDC 71335-2123 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)71335-2123Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71335-2123Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71335-2123-1	7133521230171335212301	30 TABLET in 1 BOTTLE (71335-2123-1)Marketed from Aug 31, 2022
71335-2123-2	7133521230271335212302	90 TABLET in 1 BOTTLE (71335-2123-2)Marketed from Aug 24, 2022
71335-2123-3	7133521230371335212303	28 TABLET in 1 BOTTLE (71335-2123-3)Marketed from Apr 3, 2024
71335-2123-4	7133521230471335212304	18 TABLET in 1 BOTTLE (71335-2123-4)Marketed from Apr 3, 2024
71335-2123-5	7133521230571335212305	60 TABLET in 1 BOTTLE (71335-2123-5)Marketed from Nov 22, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ezetimibe
Generic name (nonproprietary): ezetimibe
Active ingredients: Ezetimibe — 10 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Bryant Ranch PrepackNDC labeler code 71335
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209838
Marketing start: Aug 25, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Cholesterol Absorption (Physiologic effect)
Identifiers: Product ID 71335-2123_34f7bf4b-9cfb-6931-e063-6394a90abab1SPL ID 34f7bf4b-9cfb-6931-e063-6394a90abab1SPL set ID 3a80b668-51cd-42be-8497-8712b0508422RxCUI 349556UNII EOR26LQQ24
Pharmacologic class: Dietary Cholesterol Absorption Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335212301 followed by a unit qualifier and the quantity

Package 71335-2123-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 12, 2025.

Indications (excerpt from the label)

Ezetimibe tabletsareindicated: In combination with a statin, or alone when additional low-density lipoprotein cholesterol (LDL-C) lowering therapy isnot possible, as an adjunct to diet to reduce elevated LDL-C in adults with primary hyperlipidemia, including heterozygous familial hypercholesterolemia (HeFH). In combination with a statin as an adjunct todiet to reduce elevated LDL-C in pediatric patients 10 years of age and older with HeFH. In combination with fenofibrate as an adjunct todiet to reduce elevated LDL-C in adults with mixed hyperlipidemia. In combination with a statin, and other LDL-C lowering therapies, toreduce elevated LDL-C levels in adults and in pediatric patients 10 years…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71335-2123

What is NDC 71335-2123?: 71335-2123 is the product NDC for Ezetimibe, Ezetimibe 10 mg/1 tablet, listed with the FDA by Bryant Ranch Prepack. It has 5 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Ezetimibe.
What is the active ingredient?: Ezetimibe.
Who is the labeler?: Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Ezetimibe?: 40 other product NDCs are listed under this name. See all Ezetimibe NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Ezetimibe NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
ezetimibe	Ezetimibe 10 mg/1	TabletOral	Safecor Health, LLC	48433-161	48433-0161-03
Ezetimibe	Ezetimibe 10 mg/1	TabletOral	Macleods Pharmaceuticals Limited	33342-373	33342-0373-0733342-0373-1033342-0373-15
Ezetimibe	Ezetimibe 10 mg/1	TabletOral	Marlex Pharmaceuticals, Inc.	10135-787	10135-0787-0510135-0787-3010135-0787-90
ezetimibe	Ezetimibe 10 mg/1	TabletOral	Quallent Pharmaceuticals Health LLC	82009-024	82009-0024-05
Ezetimibe	Ezetimibe 10 mg/1	TabletOral	Camber Pharmaceuticals, Inc.	31722-628	31722-0628-0131722-0628-0531722-0628-10+4 more
Ezetimibe	Ezetimibe 10 mg/1	TabletOral	A-S Medication Solutions	50090-7689	50090-7689-00
Ezetimibe	Ezetimibe 10 mg/1	TabletOral	A-S Medication Solutions	50090-7690	50090-7690-0050090-7690-01
Ezetimibe	Ezetimibe 10 mg/1	TabletOral	Bryant Ranch Prepack	71335-3092	71335-3092-0171335-3092-0271335-3092-03+2 more
Ezetimibe	Ezetimibe 10 mg/1	TabletOral	Orient Pharma Co., Ltd.	76333-170	76333-0170-1276333-0170-1376333-0170-14+1 more
Ezetimibe	Ezetimibe 10 mg/1	TabletOral	A-S Medication Solutions	50090-7338	50090-7338-00

All 41 Ezetimibe NDCs

Other NDCs under ANDA 209838

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 209838
Product	Strength	Form · route	Labeler	Product NDC
Ezetimibe	Ezetimibe 10 mg/1	TabletOral	NorthStar Rx LLC	16714-813
Ezetimibe	Ezetimibe 10 mg/1	TabletOral	A-S Medication Solutions	50090-3422
Ezetimibe	Ezetimibe 10 mg/1	TabletOral	A-S Medication Solutions	50090-6630
Ezetimibe	Ezetimibe 10 mg/1	TabletOral	A-S Medication Solutions	50090-6631
Ezetimibe	Ezetimibe 10 mg/1	TabletOral	A-S Medication Solutions	50090-7099
Ezetimibe	Ezetimibe 10 mg/1	TabletOral	Aurobindo Pharma Limited	59651-052
Ezetimibe	Ezetimibe 10 mg/1	TabletOral	Proficient Rx LP	82804-064